Pluri Inc. Segment Reporting Other Item Amount
Pluri Inc. (PLUR) reported Segment Reporting Other Item Amount of $9.59 million for the 12-month period ending 2026-06-30, per its 10-K filed 2026-09-10.
Financial Statements › Notes › Segment Reporting
us-gaap:SegmentReportingOtherItemAmount · last filed 2026-09-10
- Pluri Inc. segment reporting other item amount for the quarter ending 2026-06-30 was $2.67M, a 24.27% decline year-over-year.
- Pluri Inc. segment reporting other item amount for the quarter ending 2026-03-31 was $2.19M, a 18.21% decline year-over-year.
- Pluri Inc. segment reporting other item amount for the quarter ending 2025-12-31 was $2.66M.
- Pluri Inc. segment reporting other item amount for the quarter ending 2025-09-30 was $2.51M, a 11.48% decline year-over-year.
- Pluri Inc. segment reporting other item amount for fiscal 2026 was $9.59M, a 21.66% increase from fiscal 2025.
- Pluri Inc. segment reporting other item amount for fiscal 2025 was $7.88M, a 5.06% increase from fiscal 2024.
- Pluri Inc. segment reporting other item amount for fiscal 2024 was $7.50M.
| Period end | Segment Reporting Other Item Amount 3 month | Segment Reporting Other Item Amount 6 month | Segment Reporting Other Item Amount 9 month | Segment Reporting Other Item Amount 12 month | Segment Reporting Other Item Amount 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $2.67M derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-10 | $4.86M derived: sum of 2 quarters · filed 2026-09-10 | $7.52M derived: sum of 3 quarters · filed 2026-09-10 | $9.59M 10-K · filed 2026-09-10 | |
| 2026-03-31 | $2.19M 10-Q · filed 2026-05-14 | $4.85M derived: sum of 2 quarters · filed 2026-05-14 | $6.92M 10-Q · filed 2026-05-14 | $10.88M derived: sum of 4 quarters · filed 2026-09-10 | |
| 2025-12-31 | $2.66M 10-Q · filed 2026-02-12 | $4.73M 10-Q · filed 2026-02-12 | $8.69M derived: sum of 3 quarters · filed 2026-09-10 | $11.37M derived: sum of 4 quarters · filed 2026-09-10 | |
| 2025-09-30 | $2.51M 10-Q · filed 2025-11-12 | $6.03M derived: sum of 2 quarters · filed 2026-09-10 | $8.71M derived: sum of 3 quarters · filed 2026-09-10 | $8.20M derived: sum of 4 quarters · filed 2026-09-10 | |
| 2025-06-30 | $3.53M derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-10 | $6.21M derived: sum of 2 quarters · filed 2026-09-10 | $5.70M derived: sum of 3 quarters · filed 2026-09-10 | $7.88M 10-K · filed 2026-09-10 | $9.80M 10-K · filed 2025-09-17 |
| 2025-03-31 | $2.68M 10-Q · filed 2026-05-14 | $2.17M derived: sum of 2 quarters · filed 2026-05-14 | $4.36M 10-Q · filed 2026-05-14 | ||
| 2024-12-31 | -$509.00K 10-Q · filed 2026-02-12 | $1.68M 10-Q · filed 2026-02-12 | |||
| 2024-09-30 | $2.83M 10-Q · filed 2025-11-12 | ||||
| 2024-06-30 | $7.50M 10-K · filed 2025-09-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |